Mont-Saint-Guibert, Belgium – Cardio3 BioSciences (C3BS) (Euronext Brussels and Paris: CARD), a leader in the development of regenerative therapies, announces its participation in the 18th edition of the ODDO forum, dedicated to European Midcaps, that will take place on 8 and 9 January 2015 in Lyon. The ODDO Midcap forum is renowned as the largest event dedicated to European listed companies.
This event will enable Cardio3 BioSciences to highlight its on-going development programs and strategic vision for the future to potential investors.
Patrick Jeanmart, CFO of Cardio3 BioSciences, commented: “The ODDO Midcap forum is an excellent opportunity to increase Cardio3 Biosciences’ visibility towards European investors, but most importantly it is a unique occasion to present Cardio3 Biosciences’ development potential, positioning and strategic vision.”
